Copyright © Mend Therapeutics 2013
CONTACT US
Website designed by
We are pleased to announce a collaborative project between Mend Therapeutics, Inc. and the University of Michigan, Ross School of
Business. Its scope is the evaluation and formulation of ideal market entry and commercialization plans for MEND’s innovative, development
stage, therapeutic platform aimed at treating diabetic wounds.  An early focus will be on India as the first market entry point for MEND’s global
diabetes initiatives.  The work will be conducted under the auspices of Michigan’s ExecMAP/MAP program, a Michigan Ross pioneered
program of active learning that pairs MBA students with companies and organizations to solve business problems and offer compelling
solutions.
MEND is a nonprofit pharmaceutical company that seeks to combat diabetes and its complications globally by promoting prevention and early
detection, expanding access to quality medical care, and developing and delivering life-changing therapies.   To learn more about Michigan
Ross, a world-class, top-ranked business school, please go to http://www.bus.umich.edu/
Partnerships >> Partnership News
September 18th 2013
A Non-Profit Pharmaceutical Company
Compassionate Medicine For All
 
Stay Connected